Chp Merger (CHPMU) Return on Assets ROA from the fourth quarter of 2021 to fourth quarter of 2020 and for the year 2021, Average High and Low, Fundamental Ratios from Dec 31 2021 to Dec 31 2020 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Chp Merger Corp   (CHPMU)


Chp Merger 's ROA from the fourth quarter of 2021 to the fourth quarter of 2020 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Chp Merger 's ROA in the fourth quarter of 2021?
Chp Merger Corp achieved a return on average assets (ROA) of 162.51 % in its fourth quarter of 2021, this is above CHPMU's average return on assets of 117.61%.
Chp Merger Corp assets over the 12 months ending in its fourth quarter of 2021 are valued at $198 million

Despite the company's net income deteriorating, Chp Merger was able to improve its ROA compared to the third quarter of 2021.

However, within the Healthcare sector 11 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the third quarter of 2021 from to 39.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Dec 31 2021)
IV. Quarter		 (Sep 30 2021)
III. Quarter		 (Jun 30 2021)
II. Quarter		 (Mar 31 2021)
I. Quarter		 (Dec 31 2020)
IV. Quarter
Y / Y Total Assets Change -37.74 % 33579.94 % 23883.32 % -74.48 % 21439.2 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million 322 323 311 305 -14
Return On Assets (TTM) 162.51 % 142.2 % 205.42 % 399.43 % -17.98 %
CHPMU's Total Ranking # 39 # # # #
Total Assets (TTM) in million 188 302 302 0 303
Seq. Total Assets Change -37.63 % -0.07 % 84384.57 % -99.88 % 33638.91 %
Seq. Net Income Change - - - - -

CHPMU's 5 Years Annual ROA >> Back to CHPMU Management Effectiveness >> Compare CHPMU ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 3
Sector # 12
Overall # 39

Return On Assets Statistics
High Average Low
117.61 %
117.61 %
117.61 %
(Dec 31 2021)  





Financial Statements
Chp Merger 's Assets $ 188 million CHPMU's Balance sheet
Chp Merger 's Income $ 0 million Quarterly CHPMU's Income Statement
CHPMU's Income by Division See CHPMU's Income by Division



Annual Return On Assets (Dec 31 2021)
FY 2021		 (Dec 31 2020)
FY 2020
FY
FY
FY
Y / Y Total Assets Change -37.74 % - - - -
Total Assets in million 188 303 0 0 0
Y / Y Net Income Change - - - - -
Net Income in million 22 -24 0 0 0
Annual Return On Assets 11.79 % -8.09 % - - -

CHPMU's 5 Years Annual ROA >> Back to CHPMU Management Effectiveness >> Compare CHPMU ROA to its Competitors



Comment on CHPMU's ROA in the fiscal year ending 2021
In the fiscal year 2021 ROA improved to 11.79 % compared to prior year, due to annual net income growth of % to $22.22 million, and due to decline of value in Chp Merger 's assets by -37.74 % to $188.40 million, compared to $188.40 a year before.


More Return On Assets Ratios
CHPMU's' Return on Assets at Yahoo Finance
Medical Equipment & Supplies Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
CHPMU's Roa Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for CHPMU's Competitors
Subscribers only: Roa for Chp Merger 's Suppliers
Subscribers only: Return On Assets for CHPMU's Customers

You may also want to know
CHPMU's Roi CHPMU's Inventory Turnover Ratio CHPMU's Growth Rates CHPMU's Dividend Comparisons
CHPMU's Profitability Ratios CHPMU's Asset Turnover Ratio CHPMU's Dividend Growth
CHPMU's Roe CHPMU's Valuation Ratios CHPMU's Financial Strength Ratios CHPMU's Dividend Payout Ratio



Companies with similar Return On Assets at Dec 31 2021, within Healthcare Sector ROA
Rebus Holdings Inc   299.94 %
Biovie Inc   259.51 %
Biostax Corp  244.79 %
Aceragen Inc   232.94 %
Warby Parker Inc   180.75 %
Nanomix Corp  160.89 %
Procept Biorobotics Corporation  153.60 %
Chp Merger Corp   117.61 %
Omeros Corporation  91.45 %
Altamira Therapeutics Ltd   89.02 %
Galmed Pharmaceuticals Ltd   88.51 %
Agios Pharmaceuticals Inc   87.42 %
Sinovac Biotech Ltd  84.25 %
Vyne Therapeutics Inc   67.97 %
Biontech Se  67.96 %
Nascent Biotech Inc   67.76 %
Moderna Inc   65.57 %
Vivos Therapeutics Inc   56.85 %
Ovid Therapeutics Inc   55.93 %
Ironwood Pharmaceuticals inc   55.44 %
Glucotrack Inc   50.63 %
Biomx Inc  50.23 %
Notable Labs Ltd   49.82 %
Uniqure N v   48.26 %
Silo Pharma Inc  48.22 %
Reflect Scientific Inc  45.37 %
Fulgent Genetics Inc   44.68 %
Siga Technologies Inc  44.61 %
Carisma Therapeutics Inc   40.94 %
Innoviva Inc   39.97 %

Date modified: 2026-08-30T05:22:39+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.